Autoimmune Disorder Drug Delivery Devices Market

Global Autoimmune Disorder Drug Delivery Devices Market Research Report: Forecast (2022-2027)

By Product Type (Prefilled Syringes, Auto-injectors, Infusion pumps, Nebulizers, Nasal sprays, Others), By Indication (Psoriasis, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases,... ... tory Bowel Diseases, Systemic Lupus Erythematosus, Diabetes Mellitus, Others) , By Manufacturing Type (In-House Manufacturing, Outsourced Manufacturing), By End User (Hospitals, Diagnostic centres, Ambulatory surgery centres, Others), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Company (Amgen Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., The Merck Group, Novartis International AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., UCB Pharma SA.) Read more

Healthcare
May 2022
Pages 212
Report Format: PDF, Excel, PPT

Market Definition

Autoimmune Disorder Drug Delivery Devices are specialized devices used for the delivery of drugs or therapeutic agents via a specific route of administration to treat immune system abnormalities in humans. The rise in autoimmune diseases caused by sedentary lifestyles or over activities has led to severe immune system disorders in today’s era. To selectively target immune cells in peripheral tissues or diseased tissues, the medical practitioners & government are enormously supporting huge R&D investments to focus on new approaches in drug delivery. This has led to an increase in the demand for autoimmune disorder drug delivery devices globally.

Market Insights

The Global Autoimmune Disorder Drug Delivery Devices Market is projected to grow at a CAGR of around 16.89% in terms of revenue during the forecast period, i.e., 2022-27. Increasing environmental triggers such as viruses & bacteria, use of chemical fertilizers, rising exposure to harmful ultraviolet rays, and nutritional deficiencies have resulted in the development of autoimmune diseases such as juvenile dermatomycosis & rheumatoid arthritis, among many others. According to the National Stem Cell Foundation (NCSF), globally, around 4% of the population is affected by one of more than 80 different types of autoimmune diseases.

Report Coverage	Details
Study Period	Historical Data: 2017-20
	Base Year: 2021
	Forecast Period: 2022-27
CAGR (2022-2027)	16.89%
Regions Covered	North America: USA, Canada, Mexico
	Europe: Germany, UK, Germany, France, Italy, Spain, Others
	Asia-Pacific: China, India, Japan, South Korea, Australia and Others
	South America: Brazil, and Others
	Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA
Key Companies Profiled	Amgen Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., The Merck Group, Novartis International AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., UCB Pharma SA.
Unit Denominations	USD Million/Billion

Moreover, the rising awareness among the regional governments to minimize the health risks associated with autoimmune diseases to control the fatality rates globally has driven the interest of medical practitioners to invest in R&D activities for the development of effective drug delivery systems & devices. In 2019, under the EU’s Innovative Medicine Initiative, the European Union-funded a USD89.61 million project named ‘Taxonomy, Treatments, Targets, and Remission, or 3TR'. The project aims to increase therapeutic success, reduce the risk of avoidable side effects in patients that are unlikely to benefit from the drugs prescribed, reduce the healthcare cost, and improve the quality of life.

Furthermore, heightening the adoption of advanced medical technologies in hospitals & households for effective drug deliveries & minimizing the impacts of medical side effects have portrayed enormous opportunities for autoimmune Disorder drug delivery devices globally.

Key Trends in the Market

Proliferating Trend Towards Self-Administration & Better Homecare to Support the Market Growth

A significant increase in the adoption of self-injectable devices for the treatment of autoimmunity disorders such as diabetes etc., combined with the rapid surge in hospital-acquired infections, high medical costs, and longer wait hauls, have accelerated the shift towards the use of autoimmune disorder drug delivery devices in households globally. Moreover, various companies such as Becton, Dickinson, and Insulet Corporation have launched self-injectable devices to bring economic benefits to both patients & healthcare systems. For instance, pressure-assisted auto-injectors by Antares Pharma are a form of parenteral drug delivery to address acute & chronic medical needs such as rheumatoid arthritis, allergic reactions, psoriasis, and other therapies.

Impact of Covid-19 on the Global Autoimmune Disorder Drug Delivery Devices Market

The outbreak of the Covid-19 pandemic made a relatively positive impact on the Global Autoimmune Disorder Drug Delivery Devices market The burgeoning requirement for drug delivery devices in hospitals & households to inject immunity boosters to COVID infected patients globally fueled the market demand for drug delivery devices. According to the National Institute for Health Research, 'the spread of SARS-COV-2 has created long-term autoimmune complications, including the Guillain-Barre-Syndrome, which has spurred the demand for the development of autoimmune disorder drug delivery devices for enhanced patient recoveries in the global markets.

Further, the healthcare & medical sectors experienced robust growth amidst the pandemic, despite the severe effects on nearly every industry worldwide. Moreover, with the increasing spread of the virus, the need for Drug Delivery Devices has been propelling exponentially. Still, the market had to face slight delays & limitations because of the imposition of lockdown & restrictions on logistics. However, the manufacturing of the devices is expanding robustly. Furthermore, with the gradual upliftment of lockdown & ease of norms, the Global Autoimmune Disorder Drug Delivery Devices market shall increase its production & supply and experience rapid growth in the coming years.

Introduction
1. Product Definition
2. Research Process
3. Assumptions
4. Market Segmentation
Executive Summary
Impact of COVID-19 on Global Autoimmune Drug Delivery Devices Market
Global Autoimmune Drug Delivery Devices Market Regulations & Policy
Global Autoimmune Drug Delivery Devices Market Trends & Insights
Global Autoimmune Drug Delivery Devices Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Autoimmune Drug Delivery Devices Market Hotspots & Opportunities
Global Autoimmune Drug Delivery Devices Market Outlook, 2017- 2027F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
    1. Prefilled Syringes
    2. Auto-injectors
    3. Infusion pumps
    4. Nebulizers
    5. Nasal sprays
    6. Others (Eyedropper, Transdermal patches, etc.)
  2. By Indication
    1. Psoriasis
    2. Rheumatoid Arthritis
    3. Multiple Sclerosis
    4. Inflammatory Bowel Diseases
    5. Systemic Lupus Erythematosus
    6. Diabetes Mellitus
    7. Others (Guillain Barre Syndrome, Grave’s Disease, etc.)
  3. By Manufacturing Type
    1. In-House Manufacturing
    2. Outsourced Manufacturing
  4. By End User
    1. Hospitals
    2. Diagnostic centres
    3. Ambulatory surgery centres
    4. Others (Clinics, Home care settings, etc.)
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  6. By Company
    1. Competition Characteristics
    2. Revenue Shares
North America Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Indication
  3. By Manufacturing Type
  4. By End User
  5. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
4. Canada Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
5. Mexico Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
South America Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Indication
  3. By Manufacturing Type
  4. By End User
  5. By Country
    1. Brazil
    2. Rest of South America
3. Brazil Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
Europe Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Indication
  3. By Manufacturing Type
  4. By End User
  5. By Country
    1. Germany
    2. The UK
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
3. Germany Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
4. The UK Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
5. France Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
6. Italy Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
7. Spain Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
Middle East & Africa Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Indication
  3. By Manufacturing Type
  4. By End User
  5. By Country
    1. UAE
    2. Saudi Arabia
    3. South Africa
    4. Rest of MEA
3. UAE Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
4. Saudi Arabia Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
5. South Africa Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
Asia-Pacific Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
1. Market Size & Analysis
  1. Market Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By Indication
  3. By Manufacturing Type
  4. By End User
  5. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. Rest of Asia-Pacific
3. China Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
4. India Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
5. Japan Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
6. South Korea Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
7. Australia Autoimmune Drug Delivery Devices Market Outlook, 2017-2027F
  1. Market Size & Analysis
    1. Market Revenue
  2. Market Share & Analysis
    1. By Product Type
    2. By End User
Global Autoimmune Drug Delivery Devices Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Competition Matrix
  1. Product Portfolio
  2. Target Markets
  3. Research & Development
  4. Strategic Alliances
  5. Strategic Initiatives
2. Company Profiles of top 10 companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Amgen Inc.
  2. AbbVie Inc.
  3. Bayer AG
  4. Biogen Inc.
  5. Eli Lilly and Company
  6. Bristol-Myers Squibb Company
  7. F. Hoffmann-La Roche AG
  8. GlaxoSmithKline plc
  9. Johnson & Johnson Services, Inc.
  10. The Merck Group
  11. Novartis International AG
  12. Sanofi S.A.
  13. Teva Pharmaceutical Industries Ltd.
  14. UCB Pharma SA.
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying